Preface  by Matsumura, Jon S.
Preface
Jon S. Matsumura, MD, Chicago, IllThoracic endovascular aortic repair (TEVAR) is being
incorporated into many specialty practices, including vas-
cular surgery, cardiothoracic surgery, interventional radiol-
ogy, interventional cardiology, and interventional vascular
medicine. The Society for Vascular Surgery is committed to
helping these physicians learn about this new alternative
therapy, which is associated with less morbidity and faster
patient recovery. The purpose of this syllabus is to facilitate
the safe dissemination of TEVAR into clinical practice; as
such, it is designed to supplement continuing medical
education-approved procedure training courses, device-
specific training, and other educational pathways.
Many skills—cognitive, technical, and organizational—
are needed to develop a clinical program of TEVAR. These
include experience in the care of patients with thoracic
aortic pathology, knowledge of therapeutic options, famil-
iarity with thoracic aortography and other imaging modes,
patient and device selection, device deployment, manage-
ment of large sheath access and aortoiliac injuries, periph-
eral interventional catheter-based therapies such as selective
catheterization and stenting, techniques for extra-anatomic
bypass, and recognition and treatment of early and late
complications.
This syllabus addresses each skill area in chapters au-
thored by experts in the field, among whom there is a
diversity of opinions, techniques, and approaches. This
diversity is both appropriate and instructive, since TEVAR
is still in the early stages of development. The syllabus itself,
likely the first of many that will be needed as the knowledge
base broadens, is a first step by the Society for Vascular
Surgery into endovascular thoracic coursework.
Chapters 1 to 4: General overview of TEVAR and
descending thoracic aorta trials. Dr Mark Eskandari,
from Northwestern, leads off by outlining the components
of an TEVAR center in general terms. Next, Drs James
Black, III, and Richard Cambria, from Johns Hopkins
Hospital and Massachusetts General Hospital (MGH), re-
view contemporary results with open repair of thoracic
aneurysms, comparing the practical realities of population-
based data with results at centers of excellence. The Uni-
versity of Pittsburgh group, represented by Drs Jae Sung
Cho, Shan-e-ali Haider, andMichelMakaroun, then details
the current status of the first three pivotal clinical trials in
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racic aneurysms is the only Food and Drug Administration-
approved indication for TEVAR at this time, other pathol-
ogy has been treated with endografts outside the United
States, and Dr Jon Matsumura presents the results of a
worldwide survey of practical clinical applications of tho-
racic endografts.
Chapters 5 to 7: Specific alternative pathologies. The
second group of chapters focuses on specific aspects of
TEVAR for aortic diseases other than elective aneurysm
repair, including the repair of traumatic thoracic aortic
injuries by Drs Peter Lin, Ruth Bush, Wei Zhou, Eric
Peden, and Alan Lumsden from Baylor; the pathophysiol-
ogy and treatment of aortic dissection by Drs Marvin
Atkins, Jr, James Black, III, and Richard Cambria from
MGH; and emergency stent-graft treatment, most com-
monly for rupture, by Dr Mark Farber from University of
North Carolina-Chapel Hill. The comprehensive coverage
and tabular distillation of the literature in these chapters is
distinguishing.
Chapters 8 to 11: Imaging and techniques. Techni-
cal considerations common to TEVAR are addressed in the
next four chapters, starting with Dr Kougias and his col-
leagues from Baylor who review preoperative imaging and
device sizing. They also introduce the concepts of access
evaluation and debranching that are covered in detail in
later chapters. In the well-illustrated chapter on intrapro-
cedural imaging, Drs Rodney White, Carlos Donayre, Ir-
win Walot, and George Kopchok discuss techniques for
thoracic aortography and intravascular ultrasound and spe-
cial equipment used in TEVAR. They include a helpful list
of specific ancillary supplies that are utilized at Harbor-
UCLA Medical Center. Drs Shane Parmer and Jeffrey
Carpenter, from the University of Pennsylvania, discuss
important techniques for large sheath insertion during
TEVAR that may reduce the risk of iliofemoral artery
rupture, a common and potentially fatal vascular complica-
tion. Dr Mark Morasch, from Northwestern University,
winds up with a look at patient selection, strategic ap-
proach, and the technical details of percutaneous tech-
niques for aneurysm repair, a method that avoids the fem-
oral cutdown.
Chapters 12 to 14: Debranching. The next group of
chapters addresses techniques used to treat thoracic pathol-
ogy near the arch and visceral vessels. Drs Mark Morasch
and Brian Peterson detail subclavian artery transposition
and bypass techniques that are frequently required during
TEVAR. Based on their experience, they advocate for more
liberal use of subclavian revascularization. This contrasts
with a more conservative approach by Dr Luis Sanchez
from Washington University, who also describes extra-
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Dr Farber’s experience completes the debranching options,
with indications and techniques for the distal visceral ves-
sels; this chapter discusses the broad and evolving range of
creative hybrid procedures.
Chapters 15 to 17: Complications. TEVAR is less
invasive than standard open surgical techniques but is still
associated with significant morbidity. Three chapters deal
with postprocedure complications, beginning with an ex-
ploration of acute complications. Drs Timothy Sullivan and
Thoralf Sundt III from the Mayo Clinic focus on the most
devastating neurologic complications—stroke and spinal
cord ischemia—including preventive strategies. Postopera-
tive imaging surveillance and endoleak management are
covered by Drs William Stavropoulos and Jeffrey Carpenter
in a well-illustrated chapter that details the similarities and
differences between endoleak management after TEVAR
and endovascular aneurysm repair. Other late complica-
tions are described by Drs Karthikeshwar Kasirajan, Ross
Milner, and Elliot Chaikof from Emory, with the help ofexcellent photographs and radiographs that explain the
multitude of delayed problems that can be expected.
Chapters 18 to 20: Skills and coding. In chapter 18,
the Emory group outlines the skills that they consider
essential for initiating a program. It should be noted that at
press-time, formal competency statements were being de-
bated by the relevant professional societies. Dr Gary Sea-
brook, from the Medical College of Wisconsin, provides a
chapter that clearly describes CPT coding for descending
thoracic aorta endovascular repair. Dr Tim Chuter, from
the University of California, San Francisco, concludes the
syllabus with a vision of future directions of thoracic
endografts.
The authors thank the Society for Vascular Surgery for
the privilege of contributing to this syllabus and sincerely
hope readers find the information useful in starting their
own TEVAR programs.Submitted Oct 19, 2005; accepted Oct 23, 2005.
